DaVita
DVA
#1469
Rank
C$21.48 B
Marketcap
C$334.71
Share price
1.36%
Change (1 day)
75.53%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): C$15.15

According to DaVita's latest financial reports the company's current EPS (TTM) is C$15.52. In 2025 the company made an earnings per share (EPS) of C$14.28 a decrease over its 2024 EPS that were of C$15.56.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$15.156.12%
2025C$14.28-8.25%
2024C$15.5644.94%
2023C$10.7327.26%
2022C$8.44-35.56%
2021C$13.0944.1%
2020C$9.0819.7%
2019C$7.59540.48%
2018C$1.18-76.07%
2017C$4.95-19.31%
2016C$6.14242.52%
2015C$1.79-62.87%
2014C$4.8213.43%
2013C$4.258.45%
2012C$3.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
C$34.29 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$16.02 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
C$27.44 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
C$2.72-82.45%๐Ÿ‡บ๐Ÿ‡ธ USA